Bryostatin 1 and Tamoxifen Work Together to Stop Cancer Cells
Author Information
Author(s): AT McGown, G Jayson, GR Pettit, MS Haran, TH Ward, D Crowther
Primary Institution: Paterson Institute for Cancer Research
Hypothesis
Do combinations of bryostatin 1 and tamoxifen enhance the inhibition of growth in P388 cells?
Conclusion
The combination of bryostatin 1 and tamoxifen significantly enhances the growth inhibition of P388 cells in vitro.
Supporting Evidence
- Bryostatin 1 increased growth inhibition by approximately 200-fold when combined with tamoxifen.
- Tamoxifen increased growth inhibition by over 30-fold in the presence of bryostatin 1.
- The study confirmed the synergistic effects through isobologram analysis.
Takeaway
When two cancer-fighting drugs, bryostatin 1 and tamoxifen, are used together, they can stop cancer cells from growing much better than when used alone.
Methodology
The study used various cell lines and assessed growth inhibition through the MTT assay and isobologram analysis.
Limitations
The study was conducted in vitro, which may not fully replicate the clinical situation.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website